Mitarbeiter des Rudolf-Boehm-Institutes
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Loop | Achim Aigner
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor- schnittkulturen
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
European Technology Platform on Nanomedicine
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Mitarbeiter des Rudolf-Boehm-Institutes
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Mitarbeiter des Rudolf-Boehm-Institutes
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
